Interventions that potentially limit myocardial infarct size: Overview of clinical trials

This publication has 26 references indexed in Scilit:

• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986
• A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
  New England Journal of Medicine, 1986
• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials
  European Heart Journal, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Thrombolytic therapy in patients with acute myocardial infarction.
  Circulation, 1985
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs.
  Circulation, 1979